Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › TROY › VIBRA OF SOUTHEASTERN MICHIGAN, LLC

VIBRA OF SOUTHEASTERN MICHIGAN, LLC

NPI: 1134757339 · TROY, MI 48083 · Clinical Medical Laboratory · NPI assigned 04/01/2020

$25.68M
Total Medicaid Paid
739,529
Total Claims
643,941
Beneficiaries
161
Codes Billed
2020-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialFEGAN, CLINT (SEC/TREASURER)
NPI Enumeration Date04/01/2020

Related Entities

Other providers sharing the same authorized official: FEGAN, CLINT

ProviderCityStateTotal Paid
VIBRA PHYSICIANS LLC JOHNSTOWN CO $2.15M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 12,225 $958K
2021 83,023 $3.74M
2022 109,717 $4.40M
2023 254,410 $8.18M
2024 280,154 $8.41M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 91,805 50,436 $6.62M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 76,555 67,367 $4.49M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 63,023 34,420 $2.46M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 10,073 8,125 $1.63M
87631 15,162 14,853 $1.56M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 65,788 58,954 $1.19M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 6,659 6,455 $886K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 5,508 4,480 $585K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 12,396 11,539 $464K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 20,210 20,100 $420K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2,968 2,935 $311K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 11,868 11,643 $297K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 11,907 11,593 $297K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 11,858 11,635 $297K
87481 3,046 2,949 $282K
84443 Thyroid stimulating hormone (TSH) 22,457 22,171 $274K
80061 Lipid panel 22,776 22,642 $221K
80053 Comprehensive metabolic panel 27,906 27,577 $213K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,862 2,830 $200K
82607 18,529 18,427 $190K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 7,094 6,912 $180K
80074 5,218 5,198 $177K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,253 945 $172K
83013 3,292 3,280 $161K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 2,570 2,482 $155K
83036 Hemoglobin; glycosylated (A1C) 21,870 21,747 $153K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 22,174 21,887 $125K
82728 11,859 11,758 $117K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 6,145 6,104 $105K
84481 6,365 6,319 $79K
82746 6,985 6,950 $74K
84439 10,956 10,855 $72K
87529 1,369 1,329 $68K
87511 2,520 2,453 $62K
83540 12,358 12,143 $58K
87640 2,270 2,199 $56K
87653 2,248 2,175 $55K
86803 4,787 4,754 $50K
83550 7,727 7,695 $49K
87486 1,618 1,589 $41K
87634 812 795 $41K
87086 Culture, bacterial; quantitative colony count, urine 6,983 6,779 $41K
87806 1,496 1,488 $36K
87581 1,620 1,591 $34K
86696 2,393 2,370 $33K
86003 511 488 $32K
84153 2,378 2,364 $31K
85027 6,335 6,249 $30K
84403 1,404 1,364 $26K
83735 4,795 4,759 $23K
86038 2,190 2,177 $19K
84702 1,810 1,725 $19K
86695 1,926 1,908 $18K
82670 884 875 $18K
87503 813 796 $17K
81001 6,957 6,822 $16K
87522 Neg quan hep c or qual rna 558 555 $15K
83001 1,101 1,093 $15K
87563 618 604 $15K
86592 4,337 4,273 $13K
83002 907 903 $12K
87088 1,950 1,910 $12K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 434 433 $11K
83880 384 379 $11K
84146 747 745 $10K
87077 1,662 1,632 $10K
87186 1,359 1,335 $9K
82043 2,201 2,183 $9K
84144 614 611 $9K
84436 2,998 2,964 $9K
86769 287 286 $9K
87498 576 565 $9K
82785 688 685 $8K
86140 2,143 2,129 $8K
82784 515 512 $8K
87340 987 975 $7K
84479 1,494 1,480 $7K
86480 149 148 $7K
84550 1,825 1,816 $6K
86431 1,335 1,324 $6K
85651 1,643 1,637 $5K
84100 1,454 1,447 $5K
86376 406 401 $4K
86235 151 150 $4K
88174 224 224 $4K
87480 280 277 $4K
82626 222 211 $4K
86704 467 457 $4K
87660 277 270 $4K
83970 131 128 $4K
82570 1,009 1,000 $4K
36415 Collection of venous blood by venipuncture 1,204 1,141 $4K
86225 345 344 $3K
80048 Basic metabolic panel (calcium, ionized) 568 564 $3K
83655 381 379 $3K
83690 671 667 $3K
84480 1,443 1,431 $3K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 163 160 $3K
87510 223 220 $3K
86780 314 314 $3K
85610 845 770 $3K
82150 555 552 $3K
86200 261 260 $2K
82679 137 137 $2K
87625 74 73 $2K
85652 1,101 1,090 $2K
82040 606 595 $2K
85730 481 478 $2K
82627 122 122 $2K
83721 266 261 $2K
82550 385 377 $2K
86706 232 229 $2K
84154 128 127 $2K
82172 86 84 $2K
82248 401 389 $1K
86703 145 145 $1K
81015 645 616 $1K
86901 591 590 $1K
84484 138 134 $1K
86900 560 559 $1K
86708 126 125 $1K
86141 129 129 $1K
86353 27 27 $1K
82533 83 82 $922.76
80076 201 198 $833.57
84165 99 98 $782.39
86709 134 132 $750.34
82553 81 79 $736.18
87641 23 23 $560.90
82274 41 41 $496.23
84466 54 52 $482.99
84156 168 166 $456.36
86705 82 81 $439.19
85379 56 56 $413.00
86039 51 50 $405.31
81003 259 255 $390.94
85230 30 30 $387.41
81025 61 59 $387.29
82947 158 154 $383.19
87500 14 14 $365.00
84703 57 54 $293.27
83516 30 30 $245.52
83525 30 30 $234.02
86364 24 23 $219.31
82977 44 42 $217.70
84681 14 14 $205.61
85008 431 421 $197.54
83695 16 16 $158.52
86762 12 12 $133.92
85370 13 13 $118.82
85660 27 27 $102.00
84155 53 52 $101.14
82310 33 33 $80.84
87081 16 16 $74.79
80069 13 13 $73.97
85045 26 26 $67.31
82247 17 14 $66.58
84132 30 30 $63.36
85007 98 97 $50.23
84520 28 28 $47.47
84270 95 94 $0.00